Clinical AI Safety Evaluation
An independent evaluation of a clinical AI system: whether it can be stopped and overridden, how its decisions are recorded, and whether it is ready for the regulations that apply to it. Written report, one findings call, $35–50K per engagement.
Fifteen years of healthcare product experience: kanav.net.
For health plans
You’re deploying AI for prior authorization, utilization management, or claims review. Before it touches patients, it needs independent clinical safety evaluation.
What you get
- 20-page clinical safety assessment against FDA framework, EU AI Act provisions, and clinical best practices
- Gap analysis with specific remediation recommendations
- Decision record templates customized to your clinical workflows
- Trust signal design recommendations for clinician and patient-facing surfaces
- Executive summary for the board
For healthcare AI companies
You’re building AI for clinical settings. You need safety architecture and regulatory readiness before your next funding round, customer deployment, or FDA submission.
What you get
- Safety architecture review: escalation paths, override authority, stoppability
- Regulatory readiness assessment against the frameworks that apply to your product
- Written assessment with an executive summary for the board
- Decision record framework customized to your clinical workflows
For investors
You’re evaluating a healthcare AI deal. Clinical safety risk is invisible to most diligence processes.
What you get
- Clinical validity and safety architecture assessment
- Regulatory risk analysis for the product category and expansion plans
- Written diligence memo with investment recommendation
- One call to debrief findings
Fee and process
$35-50K per engagement.
Process:
- Intake call (30 minutes): your system, timeline, and main concern
- Documentation review (async): system docs, model cards, evaluation results
- Written assessment (2–3 weeks)
- Findings call (30 minutes)